Cargando…

Glioblastoma Cells Counteract PARP Inhibition through Pro-Survival Induction of Lipid Droplets Synthesis and Utilization

SIMPLE SUMMARY: Glioblastoma multiforme (GBM) is the most common and deadly primary brain tumor in adults and one of the most aggressive cancers. The use of Poly ADP-Ribose Polymerase (PARP) inhibitors is being expanded as therapeutic alternative in multiple types of cancer beyond BRCA1/2 mutant bre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Majuelos-Melguizo, Jara, Rodríguez-Vargas, José Manuel, Martínez-López, Nuria, Delgado-Bellido, Daniel, García-Díaz, Ángel, Yuste, Víctor J., García-Macía, Marina, López, Laura M., Singh, Rajat, Oliver, F. J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8833394/ https://www.ncbi.nlm.nih.gov/pubmed/35158994 http://dx.doi.org/10.3390/cancers14030726

Ejemplares similares

PARP targeting counteracts gliomagenesis through induction of mitotic catastrophe and aggravation of deficiency in homologous recombination in PTEN-mutant glioma
por: Majuelos-Melguizo, Jara, et al.
Publicado: (2014)

PARP-1 Regulates Metastatic Melanoma through Modulation of Vimentin-induced Malignant Transformation
por: Rodríguez, María Isabel, et al.
Publicado: (2013)

Autophagy requires poly(adp-ribosyl)ation-dependent AMPK nuclear export
por: Rodríguez-Vargas, José M, et al.
Publicado: (2016)

MicroRNA-124 expression counteracts pro-survival stress responses in glioblastoma
por: Mucaj, Vera, et al.
Publicado: (2014)

The Multifactorial Role of PARP-1 in Tumor Microenvironment
por: Martí, Juan Manuel, et al.
Publicado: (2020)

New Functions of Intracellular LOXL2: Modulation of RNA-Binding Proteins
por: Eraso, Pilar, et al.
Publicado: (2023)

Chlorambucil targets BRCA1/2‐deficient tumours and counteracts PARP inhibitor resistance
por: Tacconi, Eliana MC, et al.
Publicado: (2019)

PARP-1 protein expression in glioblastoma multiforme
por: Galia, A., et al.
Publicado: (2012)

Radioiodinated PARP1 tracers for glioblastoma imaging
por: Salinas, Beatriz, et al.
Publicado: (2015)

Ku counteracts mobilization of PARP1 and MRN in chromatin damaged with DNA double-strand breaks
por: Cheng, Qiao, et al.
Publicado: (2011)

PARP Inhibition Restores Extrinsic Apoptotic Sensitivity in Glioblastoma
por: Karpel-Massler, Georg, et al.
Publicado: (2014)

PARP inhibition promotes endothelial‐like traits in melanoma cells and modulates pericyte coverage dynamics during vasculogenic mimicry
por: Fernández‐Cortés, Mónica, et al.
Publicado: (2023)

BRCAness as a Biomarker of Susceptibility to PARP Inhibitors in Glioblastoma Multiforme
por: Xavier, Mary-Ann, et al.
Publicado: (2021)

In silico screening identifies a novel small molecule inhibitor that counteracts PARP inhibitor resistance in ovarian cancer
por: Lin, Z. Ping, et al.
Publicado: (2021)

PIM kinases mediate resistance of glioblastoma cells to TRAIL by a p62/SQSTM1-dependent mechanism
por: Serrano-Saenz, Santiago, et al.
Publicado: (2019)

PARPi-FL - a Fluorescent PARP1 Inhibitor for Glioblastoma Imaging
por: Irwin, Christopher P., et al.
Publicado: (2014)

Is autophagy induction by PARP inhibitors a target for therapeutic benefit?
por: ELSHAZLY, AHMED M., et al.
Publicado: (2022)

RAB38 Facilitates Energy Metabolism and Counteracts Cell Death in Glioblastoma Cells
por: Bianchetti, Elena, et al.
Publicado: (2021)

Selective modulation by PARP-1 of HIF-1α-recruitment to chromatin during hypoxia is required for tumor adaptation to hypoxic conditions
por: Martí, Juan Manuel, et al.
Publicado: (2021)

XRCC1 counteracts poly(ADP ribose)polymerase (PARP) poisons, olaparib and talazoparib, and a clinical alkylating agent, temozolomide, by promoting the removal of trapped PARP1 from broken DNA
por: Hirota, Kouji, et al.
Publicado: (2022)

Polymer-Functionalized Mitochondrial Transplantation to Fibroblasts Counteracts a Pro-Fibrotic Phenotype
por: Baudo, Gherardo, et al.
Publicado: (2023)

Targeting EGFR Induced Oxidative Stress by PARP1 Inhibition in Glioblastoma Therapy
por: Nitta, Masayuki, et al.
Publicado: (2010)

Generation and annihilation time of magnetic droplet solitons
por: Hang, Jinting, et al.
Publicado: (2018)

ARF induction in response to DNA strand breaks is regulated by PARP1
por: Orlando, Giulia, et al.
Publicado: (2014)

A PARP1-ERK2 synergism is required for the induction of LTP
por: Visochek, L., et al.
Publicado: (2016)

Nanocell-mediated delivery of miR-34a counteracts temozolomide resistance in glioblastoma
por: Khan, Muhammad Babar, et al.
Publicado: (2021)

Pericyte–Glioblastoma Cell Interaction: A Key Target to Prevent Glioblastoma Progression
por: Pombero, Ana, et al.
Publicado: (2023)

IL-27 Counteracts Neuropathic Pain Development Through Induction of IL-10
por: Fonseca, Miriam M., et al.
Publicado: (2020)

Correction: Targeting EGFR Induced Oxidative Stress by PARP1 Inhibition in Glioblastoma Therapy
por: Nitta, Masayuki, et al.
Publicado: (2011)

Eradication of LIG4-deficient glioblastoma cells by the combination of PARP inhibitor and alkylating agent
por: Toma, Monika, et al.
Publicado: (2018)

PARP1 expression and its correlation with survival is tumour molecular subtype dependent in glioblastoma
por: Murnyák, Balázs, et al.
Publicado: (2017)

BKM120 sensitizes glioblastoma to the PARP inhibitor rucaparib by suppressing homologous recombination repair
por: Zhang, Shaolu, et al.
Publicado: (2021)

Role of PARP Inhibitors in Glioblastoma and Perceiving Challenges as Well as Strategies for Successful Clinical Development
por: Bisht, Priya, et al.
Publicado: (2022)

Methadone Potentiates the Cytotoxicity of Temozolomide by Impairing Calcium Homeostasis and Dysregulation of PARP in Glioblastoma Cells
por: Honc, Ondrej, et al.
Publicado: (2023)

Parp Inhibitors and Radiotherapy: A New Combination for Prostate Cancer (Systematic Review)
por: Rivero Belenchón, Inés, et al.
Publicado: (2023)

Landscape of Germline Mutations in DNA Repair Genes for Breast Cancer in Latin America: Opportunities for PARP-Like Inhibitors and Immunotherapy
por: Urbina-Jara, Laura Keren, et al.
Publicado: (2019)

Pharmacologic Induction of BRCAness in BRCA-Proficient Cancers: Expanding PARP Inhibitor Use
por: Abbotts, Rachel, et al.
Publicado: (2022)

MutT homolog 1 counteracts the effect of anti-neoplastic treatments in adult and pediatric glioblastoma cells
por: Versano, Ziv, et al.
Publicado: (2018)

M2 Receptor Activation Counteracts the Glioblastoma Cancer Stem Cell Response to Hypoxia Condition
por: Cristofaro, Ilaria, et al.
Publicado: (2020)

Counteracting CAR T cell dysfunction
por: Poorebrahim, Mansour, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_nf9u8v0qn8t8vu2c1nvlje3hhm